AzTrials
AzTrials

Laryngeal DystoniaNCT05150106

Characterization of Clinical Phenotypes of Laryngeal Dystonia and Voice Tremor

An observational study of Laryngeal Dystonia and Spasmodic Dysphonia, run by Massachusetts Eye and Ear Infirmary at 1 site in United States.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record

Search all trials

Trial summary

The researchers will systematically evaluate current and novel clinical voice assessment tools and measures to elucidate distinct clinical phenotypes of those with laryngeal dystonia and voice tremor. Read more about this study

Who is it for?
Ages 18 to 80 yearsHealthy volunteers can take part
Conditions the study is for
Laryngeal Dystonia, Spasmodic Dysphonia, Tremor
What is being tested?
Clinical assessments of laryngeal function
How many people
165 participants
Where
1 siteUnited States
Study dates
7 Nov 2022to 31 Aug 2027
Phase
Observational

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Study population: Patients with laryngeal dystonia Patients with voice tremor Healthy control individuals

Who may be able to join

  • Males and females of diverse racial and ethnic backgrounds;
  • Age 18-80 years;
  • Native English speakers;
  • Right-handed;
  • Normal cognitive status;
  • Patients will have laryngeal dystonia or voice tremor;
  • Healthy controls will be healthy individuals without neurological, psychiatric or otolaryngological problems.

Who cannot join

  • Subjects who are incapable of giving informed consent;
  • Pregnant or breastfeeding women until a time when they are no longer pregnant or breastfeeding. All women of childbearing potential will have a urine pregnancy test performed before MRI, which must be negative for participation in the imaging studies;
  • Subjects with a past or present medical history of (a) neurological problems, such as stroke, movement disorders (other than specified LD and VT in the patient groups), brain tumors, traumatic brain injury with loss of consciousness, ataxias, myopathies, myasthenia gravis, demyelinating diseases; (b) psychiatric problems, such as schizophrenia, bipolar depression, obsessive-compulsive disorder, alcoholism, drug dependence; (c) laryngeal problems, such as vocal fold paralysis, paresis, vocal fold nodules and polyps, carcinoma, chronic laryngitis;
  • Patients with any other form of dystonia;
  • Patients who have dystonia symptoms at rest or have a presence of mirror dystonia;
  • Patients who are not symptomatic due to treatment with botulinum toxin injections into the affected muscles. The duration of positive effects of botulinum toxin varies from patient to patient but lasts, on average, for 3-4 months. All patients will be evaluated to ensure that they are fully symptomatic and are at least 3 months post-injection before participation;
Show all 9Show fewer
  • To avoid the confounding effect of centrally acting drugs, all study participants will be questioned about any prescribed or over-the-counter medications as part of their initial screening. Those patients who receive medication(s) affecting the central nervous system will be excluded;
  • Patients will be asked whether they have undergone any head or neck surgery, which resulted in changes in regional anatomy or innervation. Because brain or laryngeal surgery may potentially lead to brain structure and function re-organization, all patients with such a history will be excluded;
  • Subjects who have certain tattoos and ferromagnetic objects in their bodies (e.g., implanted stimulators, surgical clips, prosthesis, artificial heart valve) that cannot be removed for MRI studies.

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Kristina Simonyan, MD, PhD contact

617-573-6016

simonyan_lab@meei.harvard.edu

United States1 site, 1 recruiting
  • Massachusetts Eye and Ear and University of Utah

    Boston, Massachusetts, 02114

    Kristina Simonyan, MD, PhD, 617-573-6016, Simonyan_Lab@MEEI.HARVARD.EDU

    Julie Barkmeier-Kraemer, PhD

    Recruiting

Other trials in United States

About this study

The researchers will systematically evaluate current and novel clinical voice assessment tools and measures to elucidate distinct clinical phenotypes of those with laryngeal dystonia and voice tremor.

Read the detailed description

Focal laryngeal dystonia (LD) is a rare neurological voice disorder that interrupts speaking with the intermittent onset of strained-strangled voice quality or causes voicing to stop or produce sudden breathiness. Those suffering from LD commonly report the onset of symptoms 5 years prior to achieving an accurate diagnosis, despite seeing multiple experts. Voice tremor (VT) is another neurological voice disorder that is perceived by listeners as shaky voice quality. Severe VT can result in voice interruptions that sound similar to LD resulting in misdiagnosis by experts. Recent research shows poor reliability in distinguishing those with LD from other voice disorders, largely due to the reliance on perceptual assessment methods and a wide range of clinical criteria without evidence to guide accurate diagnostic approaches. This is particularly true of VT, a voice disorder without clearly documented clinical features such that classification is not possible using current movement disorder consensus-based tremor syndrome criteria. Accurate differential diagnosis of LD from VT is essential to effective treatment planning and management as well as for accurate clinical and epidemiologic characterization and classification. The goal of this research is to systematically characterize individuals with LD and VT using currently available and novel clinical tools to determine distinguishing clinical features highly predictive of their correct diagnosis. Clinical phenotypic features will be compared between groups using acoustic, aerodynamic, laryngeal electromyography (EMG), and nasoendoscopy to quantify periodicity and task-specificity of voice patterns. Novel assessment tools and measures will also be used to study body distribution, condition of speech symptoms, and regularity or intermittency/phoneme-specificity of speech structure movement (kinematic) patterns using real-time magnetic resonance imaging and nasoendoscopy recordings during sustained phonation compared to voice- and voiceless-loaded sentences. Computational modeling will be used to assess aerodynamic, laryngeal EMG and speech structure kinematic patterns to simulate patient-specific acoustic output predictive of group membership as VT or LD. Outcomes of this research will significantly advance our clinical and scientific knowledge regarding optimal clinical tools and measures of LD and VT clinical features that result in a precise diagnosis of these neurological speech disorders.

Being tested
Clinical assessments of laryngeal function
Medical subject headings
Dysphonia, Tremor

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Clinical assessments of laryngeal functionOther

    Participants will undergo acoustic, aerodynamic, respiratory kinematic, nasoendoscopic, and laryngeal EMG recordings, as well as real-time MRI of the upper airway for comprehensive characterization of shared and distinct features of laryngeal dystonia and voice tremor.

Study groups in NCT05150106
Study groupRoleWhat they receive
Laryngeal dystoniaPatients with laryngeal dystonia (or spasmodic dysphonia)
Receives: Other: Clinical assessments of laryngeal function
Voice tremorPatients with voice tremor (essential or dystonic)
Receives: Other: Clinical assessments of laryngeal function
Healthy controlsHealthy research volunteers
Receives: Other: Clinical assessments of laryngeal function

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Differences in voice symptoms

    Clinical phenotypic features and speech structure kinematics that distinguish between laryngeal dystonia and voice tremor

    Measured: 5 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Dec 2021
  2. Study start7 Nov 2022
  3. Primary completion31 Aug 2027 (estimated)
  4. Study completion31 Aug 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case-control
Time perspective
Prospective
Enrolment
165 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05150106
Sponsor's protocol ID
2021P003143
Status last verified
Nov 2025
First submitted
27 Nov 2021
Last updated
2 Dec 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in